Rare diseases reveal that our sense of identity rests on fragile biological infrastructure, much of it operating outside ...

Detailed price information for Alterity Therapeutics Limited (PRNAF) from The Globe and Mail including charting and trades.

Parkinson’s Disease Causes, Symptoms, and Treatment Parkinson’s disease (PD) is one of the fastest-growing neurological ...

Chennai: A new AI-enabled deep brain stimulation (DBS) device, one that can read brain signals and adjust itself, will be ...

Theravance Biopharma, Inc. (NASDAQ: TBPH) today announced that it will host a virtual key opinion leader (KOL) investor event on Monday, December 8, 2025 at 10:30 AM ET. To register, click here.

In an exclusive interview, Alterity Therapeutics’ ( ATHE) CEO David Stamler met with The Fly to discuss the company, the biotech industry, ongoing trials, upcoming milestones and much more. Published ...

Alterity Therapeutics has announced a series of board changes ahead of its AGM today, positioning the biotech for its next ...

Detailed price information for Alterity Therapeutics Limited (PRNAF) from The Globe and Mail including charting and trades.

Vesiflo, Inc. today announced a major reimbursement milestone for its inFlowtm Voiding Prosthesis, following the Centers for Medicare & Medicaid Services (CMS) decision to establish national pricing ...

SMA is a rare, genetic neuromuscular condition that affects people across age groups. With treatment landscapes evolving ...

Wong envisioned a world where disabled people, particularly those from multiple marginalized backgrounds, could live freely ...

Meanwhile, Vancouver researcher, Dr. Tae-Ho Kim, was recognized with a Mitacs Innovation Award — Outstanding Innovation, for his groundbreaking work designing a self-powered continuous blood pressure ...